HIV Cure and Viral Diseases Center
-
The Wistar Institute Announces Dr. Dario Altieri Leadership Transition
The Wistar Institute, a biomedical research leader in cancer, immunology and infectious disease, announces Dario C. Altieri, M.D., Wistar’s president and CEO, director of the Ellen and…
-
Wistar Institute Announces the Recruitment of Jianliang Xu, Ph.D., to the HIV Cure and Viral Diseases Center
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, has announced the recruitment of Jianliang Xu, Ph.D., to Wistar’s HIV…
-
The Wistar Institute Appoints Two New Members to its Board of Trustees
The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome two new members to its Board…
-
Wistar Institute’s New iCure Consortium Aims to Develop Personalized HIV Treatment Strategies
A new five-year, $17 million research award has been used to fund and launch Wistar’s new iCure Consortium. The goal of the iCure Consortium is…
-
Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
The Wistar Institute recently announced the National Institutes of Health (NIH) has granted it a five-year, $17 million research award to launch iCure Consortium to…
-
Wistar Institute Opens New HIV Cure and Viral Diseases Center
The Wistar Institute recently celebrated a ribbon cutting for the opening of its new HIV Cure and Viral Diseases Center. The vision for the center…
-
Wistar Institute Invests $24M to Open New Center Dedicated to HIV Research
Wistar Institute has invested $24 million, which will be used on a new center on HIV research, writes John George for the Philadelphia Business Journal.…
Founding Partners
Advertisement
Affiliate Partners
